CD99 signals caspase-independent T cell death

被引:91
作者
Pettersen, RD
Bernard, G
Olafsen, MK
Pourtein, M
Lie, SO
机构
[1] Natl Hosp Norway, Dept Pediat Res, Oslo, Norway
[2] Natl Hosp Norway, Dept Pediat, Oslo, Norway
[3] Archet Hosp, INSERM Unit 343, Nice, France
关键词
D O I
10.4049/jimmunol.166.8.4931
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Death signaling by Fas and TNF receptors plays a major role in the control of activated mature T cells. However, the nature of the death receptors, which may be used by the immune system to control T cells that have not acquired susceptibility to Fas ligand or TNF, is not established. In this study, we demonstrate that engagement of distinct epitopes on CD99 rapidly induces T cell death by a novel caspase-independent pathway. A new mAb to these CD99 epitopes, Ad20, induces programmed cell death of transformed T cells as determined by morphological changes, phosphatidylserine exposure on the cell surface, and uptake of propidium iodide. In general, ligation of CD99 induced kinetically faster and more profound death responses as compared with the impact of anti-Fas and TNF-related apoptosis-inducing ligand (TRAIL). Ad20-induced programmed cell death was observed with seven of eight T cell lines examined, and notably, only two of these were distinctly responsive to anti-Fas and TRAIL. CD99-mediated death signaling proceeded independently of functional CD3, CD4, CD45, and p56(lck), revealed distinctions from CD47-mediated T cell death responses, and was not influenced by interference with CD47 signaling. In contrast to the effect on transformed T cell lines, Ad20-induced death responses were not observed with normal peripheral T cells. Thus, our data suggest that CD99 is linked to a novel death pathway that may have biologic relevance in control of early T cells.
引用
收藏
页码:4931 / 4942
页数:12
相关论文
共 90 条
  • [1] FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    TOUGH, TW
    DAVISSMITH, T
    BRADDY, S
    FALK, B
    SCHOOLEY, KA
    GOODWIN, RG
    SMITH, CA
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 71 - 77
  • [2] CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis
    Algeciras, A
    Dockrell, DH
    Lynch, DH
    Paya, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) : 711 - 720
  • [3] Algeciras-Schimnich A, 1999, J IMMUNOL, V162, P5205
  • [4] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [5] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [6] THE MIC2 GENE-PRODUCT - EPITOPE MAPPING AND STRUCTURAL PREDICTION ANALYSIS DEFINE AN INTEGRAL MEMBRANE-PROTEIN
    BANTING, GS
    PYM, B
    DARLING, SM
    GOODFELLOW, PN
    [J]. MOLECULAR IMMUNOLOGY, 1989, 26 (02) : 181 - 188
  • [7] Bernard G, 1997, J IMMUNOL, V158, P2543
  • [8] BERNARD G, 1995, J IMMUNOL, V154, P26
  • [9] CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4+ T cells
    Berndt, C
    Möpps, B
    Angermüller, S
    Gierschik, P
    Krammer, PH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) : 12556 - 12561
  • [10] BOEHME SA, 1995, J IMMUNOL, V155, P1703